Can antipsychotic medications cause acute confusion or delirium?

Yes, Antipsychotics Can Cause Acute Confusion and Delirium

Antipsychotic medications can themselves cause or worsen delirium (acute confusion) in patients, particularly in older adults, and this risk must be carefully weighed against any potential benefit when considering their use. 1

The Paradox: Treating and Causing Delirium

The evidence reveals a critical clinical paradox: while antipsychotics are commonly used to manage delirium symptoms, they can simultaneously trigger or exacerbate the very condition they're meant to treat.

Direct Evidence of Antipsychotic-Induced Delirium

The 2018 ESMO guidelines explicitly state: "Antipsychotics and benzodiazepines can themselves cause increased patient agitation and delirium." 1 This warning appears in multiple high-quality palliative care and delirium management guidelines, emphasizing that this is not a rare or theoretical concern but a clinically significant risk.

The mechanisms include:

• Anticholinergic effects (particularly with first-generation antipsychotics like chlorpromazine and levomepromazine) 2, 1
• Paradoxical agitation documented with levomepromazine, chlorpromazine, and benzodiazepines 2
• Sedation and cognitive impairment that can mask or worsen underlying delirium 1

Specific Antipsychotic Risks

First-generation antipsychotics (haloperidol, chlorpromazine, levomepromazine):

• Carry anticholinergic effects that directly contribute to confusion 2, 1
• Can cause paradoxical agitation rather than calming 2
• Associated with extrapyramidal symptoms that complicate clinical assessment 1

Second-generation antipsychotics (olanzapine, quetiapine, risperidone):

• May cause drowsiness and orthostatic hypotension leading to falls and confusion 1
• Quetiapine is specifically noted as "sedating" which can worsen delirium 1
• Risperidone can cause insomnia, agitation, and anxiety—symptoms that overlap with or worsen delirium 1

Clinical Implications and Safety Data

Adverse Event Rates

Recent systematic review data from 2025 shows concerning safety profiles:

• 16.8% of older adults receiving antipsychotics experienced adverse events 3
• Midazolam (a benzodiazepine often co-administered) had the highest adverse event rate at 53% 3
• These medications are "linked to short-term adverse events including respiratory depression, dysrhythmia, hypotension, and exacerbation of delirium" 3

Current Guideline Recommendations

The 2018 Critical Care Medicine guidelines recommend AGAINST routine use of antipsychotics for delirium treatment 4. The rationale is clear: studies show no benefit in delirium duration, mechanical ventilation days, ICU length of stay, or mortality, while risks remain uncertain.

However, guidelines acknowledge a narrow exception: "Patients who experience significant distress secondary to symptoms of delirium such as anxiety, fearfulness, hallucinations, or delusions, or who are agitated and may be physically harmful to themselves or others, may benefit from short-term use" until distressing symptoms resolve 4.

Practical Clinical Approach

When Antipsychotics Might Be Considered (Despite Risks)

Use only when:

1. Severe perceptual disturbances (hallucinations, illusions) cause significant patient distress 1
2. Severe agitation poses risk to patient or others 1
3. Non-pharmacological interventions have failed 3

Critical Safeguards

• Use lowest effective doses and for shortest duration possible 1
• Start PRN (as needed) rather than scheduled dosing 1
• Avoid in patients with Parkinson's disease or Lewy body dementia (high risk of severe extrapyramidal symptoms) 1
• Monitor for paradoxical worsening of agitation or confusion 2
• Discontinue promptly when symptoms resolve—patients often remain on these medications unnecessarily after discharge 4

High-Risk Populations

Older adults are especially vulnerable:

• Brain sensitivity to psychoactive drugs increases with age 5
• Polypharmacy and multimorbidity amplify risks 6
• The 2019 AGS Beers Criteria caution about antipsychotic use in older adults due to increased mortality risk 7

The Bottom Line

Antipsychotics are a double-edged sword in delirium management: they can cause the very confusion they're prescribed to treat. The evidence strongly supports prioritizing non-pharmacological interventions and using antipsychotics only as a last resort for severe, distressing symptoms or safety concerns, at the lowest dose, for the shortest duration. Clinicians must actively monitor for worsening confusion and discontinue these medications as soon as possible to prevent iatrogenic harm.